US biotech major Gilead Sciences has presented data to show that twice-yearly Sunlenca (lenacapavir) has a sustained impact on health-related quality of life in 25 July 2023
Healthcare investor TVM Capital Life Science has joined forces with Tillotts Pharma to launch a new biotech company, Mage Biologics, backed by $28 million in fi 21 July 2023
Dublin-headquartered protein specialist Prothena has outlined research it intends to present at the upcoming Alzheimer’s Association International Conference (A 12 July 2023
Central nervous system (CNS) specialist Neuraxpharm has established outposts in Brazil and Mexico, as part of its strategy to globalize its operations outside E 12 July 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.